言語を選択
新規登録

TROP2

TROP2 詳細

英語名Tumor-associated calcium signal transducer 2市販薬剤の数3
治験薬の数27ターゲットの別称Tumor-associated calcium signal transducer 2，M1S1，TROP2，TACSTD2，Pancreatic carcinoma marker protein GA733-1，Tumor Associated Calcium Signal Transducer 2，GA733-1，Membrane Component， Chromosome 1， Surface Marker 1，Gastrointestinal Tumor-Associated Antigen GA7331，Pancreatic Carcinoma Marker Protein GA7331，Cell surface glycoprotein Trop-2，Membrane component chromosome 1 surface marker 1，40kD Glycoprotein， Identified By Monoclonal Antibody GA733，Cell Surface Glycoprotein TROP2，Epithelial Glycoprotein-1，Truncated TACSTD2，GA7331，EGP-1，EGP1，GP50，Trophoblast Cell Surface Antigen 2
研究＆開発段階Approved
英語名Tumor-associated calcium signal transducer 2
ターゲットの別称Tumor-associated calcium signal transducer 2，M1S1，TROP2，TACSTD2，Pancreatic carcinoma marker protein GA733-1，Tumor Associated Calcium Signal Transducer 2，GA733-1，Membrane Component， Chromosome 1， Surface Marker 1，Gastrointestinal Tumor-Associated Antigen GA7331，Pancreatic Carcinoma Marker Protein GA7331，Cell surface glycoprotein Trop-2，Membrane component chromosome 1 surface marker 1，40kD Glycoprotein， Identified By Monoclonal Antibody GA733，Cell Surface Glycoprotein TROP2，Epithelial Glycoprotein-1，Truncated TACSTD2，GA7331，EGP-1，EGP1，GP50，Trophoblast Cell Surface Antigen 2
市販薬剤の数3
治験薬の数27
研究＆開発段階Approved

お問い合わせ

TROP2分子の別称

TROP2

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
SHR-A1921SHR-A1921; SHRA1921; SHR-1921Phase 3 ClinicalSuzhou Suncadia Biopharmaceuticals Co Ltd, Shanghai Hengrui Pharmaceutical Co LtdSolid tumours; Ovarian Neoplasms; Carcinoma, Ovarian Epithelial; Triple Negative Breast Neoplasms; Salivary Gland Neoplasms; Neoplasms; Breast Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Metastatic breast cancer; Brain metastases; Carcinoma, Non-Small-Cell Lung
詳細
ESG-401STI-3258; OQY-3258; ESG-401Phase 3 ClinicalShanghai Escugen Biotechnology Co LtdOvarian Neoplasms; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms; Neoplasms; Urinary Bladder Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Metastatic breast cancer
詳細
FDA018 Antibody Drug ConjugateFDA018-ADC; FDA-018-ADCPhase 3 ClinicalShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co LtdSolid tumours; Neoplasms; Triple Negative Breast Neoplasms; Breast Neoplasms
詳細
GQ-1010PBI-410; GQ1010; BHV1510; BHV-1510; GQ-1010Phase 2 ClinicalGeneQuantum Healthcare (Suzhou) Co LtdSolid tumours; Carcinoma; Triple Negative Breast Neoplasms; Carcinoma, Non-Small-Cell Lung
詳細
Trop2 CAR-NK cell therapy(Henan Provincial Cancer Hospital)Phase 2 ClinicalCarcinoma, Non-Small-Cell Lung
詳細
OBI-992BSI-992; BSI992; R-992; OBI-992Phase 2 ClinicalBoaoxin Biotechnology(Nanjing) Co LtdSolid tumours; Stomach Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Non-Small-Cell Lung
詳細
JSKN-016JSKN016; JSKN-016Phase 2 ClinicalJiangsu Alphamab Biopharmaceuticals Co LtdSolid tumours; Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung
詳細
HS-20105HS-20105; HS20105Phase 2 ClinicalHansoh BioMedical R&D CompanySolid tumours
詳細
IBI130IBI130; IBI-130Phase 2 ClinicalInnovent Biologics(Suzhou) Co LtdSolid tumours; Neoplasm Metastasis
詳細
Anti TROP2 antibody drug conjugate ADC（Fudan University）Phase 2 ClinicalFudan UniversityTriple Negative Breast Neoplasms
詳細
9MW-29219MW2921; 9MW-2921Phase 2 ClinicalMabwell (Shanghai) Bioscience Co LtdSolid tumours
詳細
MHB036CMHB-036CPhase 2 ClinicalMinghui Pharmaceutical Pty LtdSolid tumours; Neoplasms; Breast Neoplasms; Lung Neoplasms
詳細
BAT-8008BAT-8008; BAT8008Phase 2 ClinicalBio-Thera Solutions LtdSolid tumours; Triple Negative Breast Neoplasms
詳細
DB-1305DB1305; BNT325; BNT-325; DB-1305Phase 2 ClinicalDuality Biologics (Suzhou) Co LtdSolid tumours
詳細
BIO-106BIO-106Phase 2 ClinicalHangzhou Baikai Biopharmaceutical Co LtdSolid tumours; Neoplasms
詳細
BL-M02D1Phase 2 ClinicalBaili-Bio (Chengdu) Pharmaceutical Co Ltd, Sichuan Baili Pharmaceutical Co LtdSolid tumours; Triple Negative Breast Neoplasms; Digestive System Neoplasms; Breast Neoplasms; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung
詳細
LCB-84LCB-84Phase 2 ClinicalLegochem Biosciences IncSolid tumours
詳細
JS-108DAC-002; JS-108; DAC-002/JS108Phase 1 ClinicalHangzhou Dac Biotech Company LtdSolid tumours; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms
詳細
IBI-3007IBI3007; IBI-3007Phase 1 ClinicalInnovent Biologics(Suzhou) Co LtdSolid tumours
詳細
HS-20124HS-20124; HS20124Phase 1 ClinicalHansoh BioMedical R&D CompanySolid tumours
詳細
IBR-822IBR822; IBR-822Phase 1 ClinicalImbioray (Hangzhou) Biomedicine Co LtdSolid tumours
詳細
DXC-1002DXC1002; DXC-1002Phase 1 ClinicalHangzhou Dac Biotech Company LtdSolid tumours
詳細
DS-001DS001; DS-001Phase 1 ClinicalShanghai Institute Of Materia Medica, Chinese Academy Of Sciences, Dartsbio Pharmaceuticals LtdNeoplasms
詳細
FZ-AD004FZ-AD004Phase 1 ClinicalShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co LtdSolid tumours
詳細
U87 CAR-T cell therapy(Unicar-Therapy Bio-Medicine Technology)U-87Phase 1 ClinicalShanghai Unicar-Therapy Bio-Medicine Technology Co LtdHead and Neck Neoplasms; Solid tumours; Nasopharyngeal Neoplasms; Pancreatic Neoplasms; Neoplasms; Triple Negative Breast Neoplasms; Lung Neoplasms
詳細
BCG-011DM-001; BCG-011Phase 1 ClinicalBiocytogen Pharmaceuticals (Beijing) Co LtdSolid tumours; Triple Negative Breast Neoplasms; Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung
詳細
MT-302MT-302Phase 1 ClinicalMyeloid Therapeutics IncCarcinoma; Colonic Neoplasms; Breast Neoplasms; Lung Neoplasms
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Sacituzumab govitecanIMMU-132; TROP-2-SN-38; IMMU0132; GS-0132; IMMU-0132ApprovedImmunomedics Inc, Gilead Sciences IncTrodelvy, 拓达维, TRODELVYUnited StatesTriple Negative Breast NeoplasmsImmunomedics Inc2020-04-22Brain metastases; Mesothelioma; Urinary Bladder Neoplasms; Klatskin Tumor; Breast Neoplasms; Cholangiocarcinoma; Prostatic Neoplasms; Bile Duct Neoplasms; Metastatic breast cancer; Hormone-Resistant Prostate Neoplasms; Thymoma; Esophageal Squamous Cell Carcinoma; Endometrial Neoplasms; Thyroid Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Solid tumours; Thyroid Carcinoma, Anaplastic; Salivary Gland Neoplasms; Carcinoma, Ovarian Epithelial; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Glioblastoma; Carcinoma, Transitional Cell; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Esophageal Neoplasms; Biliary Tract Neoplasms; Ovarian Neoplasms; Liver Failure
詳細
Datopotamab deruxtecanDS-1062a; DS-1062; Dato-DXd; S-1062aApprovedDaiichi Sankyo Co LtdDATROWAY, DatrowayJapanBreast NeoplasmsDaiichi Sankyo Co Ltd2024-12-27Solid tumours; Ovarian Neoplasms; Biliary Tract Neoplasms; Carcinoma; Stomach Neoplasms; Triple Negative Breast Neoplasms; Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Lung Neoplasms; Metastatic breast cancer; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis
詳細
Sacituzumab tirumotecanSKB-264; MK-2870; SKB264; sac-TMTApprovedKlus Pharma Inc佳泰莱Mainland ChinaTriple Negative Breast NeoplasmsSichuan Kelun-Biotech Biopharmaceutical Co Ltd2024-11-22Small Cell Lung Carcinoma; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Carcinoma, Pancreatic Ductal; Metastatic breast cancer; Endometrial Neoplasms; Colorectal Neoplasms; Breast Neoplasms; Urinary Bladder Neoplasms; Solid tumours; Carcinoma, Ovarian Epithelial; Triple Negative Breast Neoplasms; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Esophageal Neoplasms; Carcinoma; Biliary Tract Neoplasms
詳細
  • 詳細
  • お問い合わせ
  • 市販薬剤に関する情報
  • 治験薬に関する情報
共有：

採用情報法的規制サイトマッププライバシーポリシー利用規約
ウェブサイトに関するフィードバック
お問い合わせ

お問い合わせ
グローバル：+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8